Mitsui Chemicals’ Life & Healthcare unit holds steady as group revenue plunges in FY2025/26
Mitsui Chemicals has reported a 2.9 percent year‑on‑year increase in revenue to 259 billion Japanese yen (€1.4bn) for its Life & Healthcare Solutions division in fiscal 2025/2026. The full‑year topline reflects an acceleration in the fourth quarter, as nine‑month sales were up 1.3 percent, though the result falls short of ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.